Tandem Diabetes Care, Inc.

Fundamentals4.0
Price Action3.0
News Sentiment5.0
AI Rating
5.0

Key Drivers

  • Improving Margins
  • Negative Cash Flow
  • Rising Leverage

AI
AI Summary

5.0

TNDM is a high-risk turnaround: its 57% gross margin creates a credible path to breakeven, but investors should wait for accelerating revenue and materially lower cash burn before treating the low sales multiple as value, given sharply higher debt and shrinking cash.

MarginExpansion
LeverageRisk
TurnaroundExecution‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

4.0

Key Financial Insights:

  • •Improving Margins
  • •Negative Cash Flow
  • •Rising Leverage

TNDM's improving margins and liquidity are outweighed by persistent losses, negative cash flow, and sharply higher leverage, warranting caution until profitability and debt metrics stabilize.

Leverage
Liquidity

Price Behavior

3.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • •Lower highs
  • •Support testing
  • •Oversold momentum

TNDM remains bearish after a 25% last-month decline, with $16.28 support at risk unless it reclaims $17.53 despite oversold momentum.

Bearish
Oversold
Support Level: $16.28
Resistance Level: $17.53; $19.11–$19.88

Sharp selling accelerated between

Sentiment & News

5.0

Key News Insights:

  • •Product Expansion
  • •Estimate Upgrades
  • •Share Volatility

Tandem's expanding pump strategy and favorable estimate revisions support investor interest despite sharp share volatility and competitive pressures.

TNDM
InsulinPumps

The news is modestly positive for TNDM's near-term outlook, though competitive and macro risks remain